Hemodynamic Thresholds for Precapillary Pulmonary Hypertension

Background Hemodynamic differentiation between pulmonary arterial hypertension (PAH) and postcapillary pulmonary hypertension (PH) is important because treatment options are strikingly different for the two disease subsets. Whereas patients with PAH can be treated effectively with targeted therapies, their use in postcapillary PH is currently not recommended. Our aim was to establish an algorithm to identify patients who are likely to experience a significant hemodynamic treatment response. Methods We determined hemodynamic cutoffs to discriminate between idiopathic PAH and postcapillary PH in a large database of 4,363 stable patients undergoing first diagnostic right and left heart catheterizations. In a second step, we performed a patient-level pooled analysis of four randomized, placebo-controlled trials including 541 patients with PAH who received treprostinil or placebo, to validate hemodynamic cutoffs with regard to treatment response. Results Receiver operating characteristic analysis identified mean pulmonary arterial wedge pressure (mPAWP)   20 mm Hg or a combination of both had a significant placebo-corrected improvement in hemodynamics. Conclusions mPAWP  20 mm Hg identify patients with PAH who are likely to have significant hemodynamic improvement with prostacyclin treatment.